France It may not have experienced the same double digit growth of a few years ago, but the French aesthetics market was still looking radiant in 2013. According to Millennium Research Group, the market was worth ("54.4m, up 3.2% compared with 2012, including both facial injectable procedures, which grew by 3 % to C37.6m and breast implants, which declined by just over 1 % to 016.8m. Figures from the International Society of Aesthetic Plastic Surgery (ISAPS) reveal that botulinum toxin accounts for 39% of non-invasive aesthetic procedures while hyaluronic acid fillers take 32%. In terms of plastic surgery, breast augmentation is the most practised intervention, accounting for 20% of surgeries.
展开▼
机译：法国它可能没有像几年前一样经历过两位数的增长，但是法国的美学市场在2013年仍然看好辐射。根据Millennium Research Group的调查，该市场的价值（“ 5440万，比2012年增长3.2％包括面部可注射手术（增长了3％，达到C37.6m）和乳房植入物（下降了仅超过1％，达到016.8m）;国际美容整形外科协会（ISAPS）的数据显示，肉毒杆菌毒素占39非侵入性的美容程序占30％，而透明质酸填充剂占32％，就整形手术而言，隆胸是最常用的干预手段，占外科手术的20％。
展开▼
